Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan

Buttner FH, Hughes CE, Margerie D, Lichte A, Tschesche H, Caterson B, Bartnik E (1998)
BIOCHEMICAL JOURNAL 333: 159-165.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Abstract / Bemerkung
The recent detection of membrane type 1 matrix metallo-proteinase (MT1-MMP) expression in human articular cartilage [Buttner, Chubinskaya, Margerie, Huch, Flechtenmacher, Cole, Kuettner, and Bartnik (1997) Arthritis Rheum. 40, 704-709] prompted our investigation of MT1-MMP's catabolic activity within the interglobular domain of aggrecan. For these studies we used rAAg1(mut), a mutated form of the recombinant fusion protein (rAgg1) that has been used as a substrate to monitor 'aggrecanase' catabolism in vitro [Hughes, Buttner, Eidenmuller, Caterson and Bartnik (1997) J. Biol. Chem. 272, 20269-20274]. The rAgg1 was mutated (G(332) to A) to avoid the generation of a splice variant seen with the original genetic construct, which gave rise to heterogeneous glycoprotein products. This mutation yielded a homogeneous recombinant product. Studies in vitro with retinoic acid-stimulated rat chondrosarcoma cells indicated that the rAgg1(mut) substrate was cleaved at the 'aggrecanase' site equivalent to Glu(373)-Ala(374) (human aggrecan sequence enumeration) in its interglobular domain sequence segment. The differential catabolic activities of the recombinant catalytic domain (ed) of MT1-MMP and matrix metalloproteinases (MMPs) 3 and 8 were then compared by using this rAgg1(mut) as substrate. Coomassie staining of rAAg1(mut) catabolites separated by SDS/PAGE showed similar patterns of degradation with all three recombinant enzymes. However, comparative immunodetection analysis, with neoepitope antibodies BC-3 (anti-ARGS...) and BC-14 (anti-FFGV...) to distinguish between 'aggrecanase' and MMP-generated catabolites, indicated that the catalytic domain of MT1-MMP exhibited strong 'aggrecanase' activity, cdMMP-8 weak activity and cdMMP-3 no activity. In contrast, cdMMP-3 and cdMMP-8 led to strongly BC-14-reactive catabolic fragments, whereas cdMT1-MMP resulted in weak BC-14 reactivity. N-terminal sequence analyses of the catabolites confirmed these results and also identified other potential minor cleavage sites within the interglobular domain of aggrecan. These results indicate that MT1-MMP is yet another candidate for 'aggrecanase' activity in vivo.
Erscheinungsjahr
Zeitschriftentitel
BIOCHEMICAL JOURNAL
Band
333
Seite(n)
159-165
ISSN
PUB-ID

Zitieren

Buttner FH, Hughes CE, Margerie D, et al. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. BIOCHEMICAL JOURNAL. 1998;333:159-165.
Buttner, F. H., Hughes, C. E., Margerie, D., Lichte, A., Tschesche, H., Caterson, B., & Bartnik, E. (1998). Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. BIOCHEMICAL JOURNAL, 333, 159-165.
Buttner, F. H., Hughes, C. E., Margerie, D., Lichte, A., Tschesche, H., Caterson, B., and Bartnik, E. (1998). Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. BIOCHEMICAL JOURNAL 333, 159-165.
Buttner, F.H., et al., 1998. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. BIOCHEMICAL JOURNAL, 333, p 159-165.
F.H. Buttner, et al., “Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan”, BIOCHEMICAL JOURNAL, vol. 333, 1998, pp. 159-165.
Buttner, F.H., Hughes, C.E., Margerie, D., Lichte, A., Tschesche, H., Caterson, B., Bartnik, E.: Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan. BIOCHEMICAL JOURNAL. 333, 159-165 (1998).
Buttner, FH, Hughes, CE, Margerie, D, Lichte, A, Tschesche, Harald, Caterson, B, and Bartnik, E. “Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1(mut) at the 'aggrecanase' and the MMP sites - Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan”. BIOCHEMICAL JOURNAL 333 (1998): 159-165.

35 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Increased metalloproteinase activity in the hippocampus following status epilepticus.
Dubey D, McRae PA, Rankin-Gee EK, Baranov E, Wandrey L, Rogers S, Porter BE., Epilepsy Res 132(), 2017
PMID: 28292736
An enzyme-sensitive PEG hydrogel based on aggrecan catabolism for cartilage tissue engineering.
Skaalure SC, Chu S, Bryant SJ., Adv Healthc Mater 4(3), 2015
PMID: 25296398
Isolation of dendritic-cell-like S100β-positive cells in rat anterior pituitary gland.
Horiguchi K, Fujiwara K, Yoshida S, Higuchi M, Tsukada T, Kanno N, Yashiro T, Tateno K, Osako S, Kato T, Kato Y., Cell Tissue Res 357(1), 2014
PMID: 24737488
MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
Durigova M, Nagase H, Mort JS, Roughley PJ., Matrix Biol 30(2), 2011
PMID: 21055468
Antibodies and immunohistochemistry in extracellular matrix research.
Hayes AJ, Hughes CE, Caterson B., Methods 45(1), 2008
PMID: 18442701
Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
Gendron C, Kashiwagi M, Lim NH, Enghild JJ, Thøgersen IB, Hughes C, Caterson B, Nagase H., J Biol Chem 282(25), 2007
PMID: 17430884
Blocking aggrecanase cleavage in the aggrecan interglobular domain abrogates cartilage erosion and promotes cartilage repair.
Little CB, Meeker CT, Golub SB, Lawlor KE, Farmer PJ, Smith SM, Fosang AJ., J Clin Invest 117(6), 2007
PMID: 17510707
Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI, Lee YM, Seo SK, Kang BS, Chang Y, Lee YS, Fini ME, Kang SS, Jung JC., J Cell Biochem 101(5), 2007
PMID: 17295208
Differential regulation of matrix degrading enzymes in a TNFalpha-induced model of nucleus pulposus tissue degeneration.
Séguin CA, Bojarski M, Pilliar RM, Roughley PJ, Kandel RA., Matrix Biol 25(7), 2006
PMID: 16934445
Matrix metalloproteinases and their function in myocardium.
Kukacka J, Průsa R, Kotaska K, Pelouch V., Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149(2), 2005
PMID: 16601761
Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade.
Dreier R, Grässel S, Fuchs S, Schaumburger J, Bruckner P., Exp Cell Res 297(2), 2004
PMID: 15212936
Delayed tooth eruption in membrane type-1 matrix metalloproteinase deficient mice.
Bartlett JD, Zhou Z, Skobe Z, Dobeck JM, Tryggvason K., Connect Tissue Res 44 Suppl 1(), 2003
PMID: 12952213
Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3.
van der Laan WH, Quax PH, Seemayer CA, Huisman LG, Pieterman EJ, Grimbergen JM, Verheijen JH, Breedveld FC, Gay RE, Gay S, Huizinga TW, Pap T., Gene Ther 10(3), 2003
PMID: 12571631
ADAMTS4 cleaves at the aggrecanase site (Glu373-Ala374) and secondarily at the matrix metalloproteinase site (Asn341-Phe342) in the aggrecan interglobular domain.
Westling J, Fosang AJ, Last K, Thompson VP, Tomkinson KN, Hebert T, McDonagh T, Collins-Racie LA, LaVallie ER, Morris EA, Sandy JD., J Biol Chem 277(18), 2002
PMID: 11854269
Matrix metalloproteinases are involved in C-terminal and interglobular domain processing of cartilage aggrecan in late stage cartilage degradation.
Little CB, Hughes CE, Curtis CL, Janusz MJ, Bohne R, Wang-Weigand S, Taiwo YO, Mitchell PG, Otterness IG, Flannery CR, Caterson B., Matrix Biol 21(3), 2002
PMID: 12009333
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T., Arthritis Rheum 46(10), 2002
PMID: 12384923
Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration.
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M., J Cell Biol 153(5), 2001
PMID: 11381077
Host metalloproteinases in Lyme arthritis.
Hu LT, Eskildsen MA, Masgala C, Steere AC, Arner EC, Pratta MA, Grodzinsky AJ, Loening A, Perides G., Arthritis Rheum 44(6), 2001
PMID: 11407701
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
Tortorella MD, Malfait AM, Deccico C, Arner E., Osteoarthritis Cartilage 9(6), 2001
PMID: 11520168
Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M., EMBO J 20(17), 2001
PMID: 11532942
Catabolism of aggrecan, decorin and biglycan in tendon.
Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM., Biochem J 350 Pt 1(), 2000
PMID: 10926842
Mechanisms involved in cartilage proteoglycan catabolism.
Caterson B, Flannery CR, Hughes CE, Little CB., Matrix Biol 19(4), 2000
PMID: 10963994
Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis.
van Meurs JB, van Lent PL, Holthuysen AE, Singer II, Bayne EK, van den Berg WB., Arthritis Rheum 42(6), 1999
PMID: 10366105
Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
Little CB, Flannery CR, Hughes CE, Mort JS, Roughley PJ, Dent C, Caterson B., Biochem J 344 Pt 1(), 1999
PMID: 10548534

41 References

Daten bereitgestellt von Europe PubMed Central.

The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B.
Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA., J. Biol. Chem. 267(27), 1992
PMID: 1326552
Use of T7 RNA polymerase to direct expression of cloned genes.
Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW., Meth. Enzymol. 185(), 1990
PMID: 2199796
Mechanism of catabolism of aggrecan by articular cartilage.
Ilic MZ, Handley CJ, Robinson HC, Mok MT., Arch. Biochem. Biophys. 294(1), 1992
PMID: 1550337
CD44 is the principal cell surface receptor for hyaluronate.
Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B., Cell 61(7), 1990
PMID: 1694723
Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.
Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA., J. Biol. Chem. 266(24), 1991
PMID: 1874716
A calcium-dependent antibody for identification and purification of recombinant proteins.
Prickett KS, Amberg DC, Hopp TP., BioTechniques 7(6), 1989
PMID: 2698650
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells.
Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, Bauer EA, Goldberg GI., Proc. Natl. Acad. Sci. U.S.A. 84(19), 1987
PMID: 3477804
Protein sequence analysis: automated microsequencing.
Hunkapiller MW, Hood LE., Science 219(4585), 1983
PMID: 6687410
Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
Ilic MZ, Mok MT, Williamson OD, Campbell MA, Hughes CE, Handley CJ., Arch. Biochem. Biophys. 322(1), 1995
PMID: 7574678
Structure of the human aggrecan gene: exon-intron organization and association with the protein domains.
Valhmu WB, Palmer GD, Rivers PA, Ebara S, Cheng JF, Fischer S, Ratcliffe A., Biochem. J. 309 ( Pt 2)(), 1995
PMID: 7626017
Cell-mediated catabolism of aggrecan. Evidence that cleavage at the "aggrecanase" site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain.
Lark MW, Gordy JT, Weidner JR, Ayala J, Kimura JH, Williams HR, Mumford RA, Flannery CR, Carlson SS, Iwata M., J. Biol. Chem. 270(6), 1995
PMID: 7852317
Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan.
Fosang AJ, Last K, Neame PJ, Murphy G, Knauper V, Tschesche H, Hughes CE, Caterson B, Hardingham TE., Biochem. J. 304 ( Pt 2)(), 1994
PMID: 7998967
A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M., Nature 370(6484), 1994
PMID: 8015608
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.
Fosang AJ, Last K, Knauper V, Neame PJ, Murphy G, Hardingham TE, Tschesche H, Hamilton JA., Biochem. J. 295 ( Pt 1)(), 1993
PMID: 8216228
Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis.
Caterson B, Hughes CE, Roughley P, Mort JS., Acta Orthop Scand Suppl 266(), 1995
PMID: 8553840
Degradation of cartilage aggrecan by collagenase-3 (MMP-13).
Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ., FEBS Lett. 380(1-2), 1996
PMID: 8603731
Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase.
Cole AA, Chubinskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, Hasty KA, Kuettner KE., J. Biol. Chem. 271(18), 1996
PMID: 8631924
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G., J. Biol. Chem. 271(29), 1996
PMID: 8663255
Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y., J. Biol. Chem. 272(4), 1997
PMID: 8999957
Expression of membrane type 1 matrix metalloproteinase in human articular cartilage.
Buttner FH, Chubinskaya S, Margerie D, Huch K, Flechtenmacher J, Cole AA, Kuettner KE, Bartnik E., Arthritis Rheum. 40(4), 1997
PMID: 9125252
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, Singer II, Donatelli SA, Weidner JR, Williams HR, Mumford RA, Lohmander LS., J. Clin. Invest. 100(1), 1997
PMID: 9202061
Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, Okada Y., Am. J. Pathol. 151(1), 1997
PMID: 9212749
Utilization of a recombinant substrate rAgg1 to study the biochemical properties of aggrecanase in cell culture systems.
Hughes CE, Buttner FH, Eidenmuller B, Caterson B, Bartnik E., J. Biol. Chem. 272(32), 1997
PMID: 9242707
Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain.
Sandy JD, Neame PJ, Boynton RE, Flannery CR., J. Biol. Chem. 266(14), 1991
PMID: 2026585
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases.
Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM, Mainardi CL., J. Biol. Chem. 265(20), 1990
PMID: 2164002
Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury.
Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW., Arthritis Rheum. 35(1), 1992
PMID: 1370619

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 9639575
PubMed | Europe PMC

Suchen in

Google Scholar